The post-translational modification of proteins by tyrosine phosphorylation plays a critical role in signal transduction. As a consequence, this modification can dramatically alter the protein's activity or stability. To study the biological and biochemical properties of these proteins in vitro, a source for obtaining an adequate amount of phosphorylated protein is essential. In many instances, the phosphoprotein is expressed in cell systems such as baculovirus/insect cells or eucaryotic cell lines expressing an appropriate kinase. However, the use of these methods is relatively time consuming. Alternatively, the recombinant proteins can be phosphorylated in vitro with purified kinase, but the cost associated with these procedures is often prohibitive.
Phosphorylation of mammalian proteins expressed in bacteria has been described (2, 3, 7) . In a commercially available system, Epicurian Coli ® TKX1 Competent cells (Stratagene, La Jolla, CA, USA), a mammalian tyrosine kinase encoding plasmid under the control of the procaryotic trp promoter is used to phosphorylate target proteins expressed in E. coli. If the target protein has an affinity tag or is fused to glutathione-S-transferase (GST) or maltose binding protein (MBP), then the production and purification of large amount of this protein is relatively rapid and easy. However, the use of the trp promoter is rather cumbersome. To induce the expression of the kinase, the cells must be transferred to M9 minimal medium and treated with indole acrylic acid. To make this method of generating phosphoproteins more "user friendly", we generated a plasmid that controls the expression of the tyrosine kinase with the hybrid tac promoter (4). This plasmid, pTac-elk, encodes a rat tyrosine kinase (elk) (5) whose expression is induced by treatment with isopropyl-β-D-thiogalactosidase (IPTG).
The plasmid also encodes tetracycline resistance, making it easy to co-select with many other conventional ampicillin-resistant vectors.
The plasmid harbored in the E. coli strain TKX1 (Stratagene) was isolated. The trp promoter was replaced by tac promoter from pGEX-2T (Amersham Pharmacia Biotech, Piscatatway, NJ, USA) by a two-step PCR method (shown schematically in Figure 1 ). In brief, a pair of primers was designed containing an initiation ATG in the middle and homology to the tac promoter sequence of pGEX2T upstream and homology to elk coding region downstream (plus-tac: 5′-ttcacacaggaaacagtattcATGGAAGCTGTCCGGGAGTTT-GCC-3′; minus-tac: 5 ′-GGCAAACTCCCGGACAGCTTCCATgaatactgtttcctgtgtgaa-3′; the lowercase letters indicate the sequence from pGEX2T, and the uppercase letters indicate the sequence from elk). The PCR product containing lac operator and tac promoter from pGEX2T were generated by primer up-tac (5′-gcgcccatggcatcataacggttctggc-3′) and minus-tac, and a NcoI site (underlined) was added to its 5′ end.
The second PCR product containing the elk segment was amplified with primer down-elk (5′-ctttgcacaccaggttgc-3′) and plus-tac. The resulting two PCR products were purified, mixed together along with the flanking primers up-tac and down-elk, and reamplified. This PCR product was restricted with NcoI and ApaLI and gel purified. This fragment was used to replace the NcoI and ApaLI fragment of the progenitor plasmid (containing the trp promoter). The integrity of the resulting plasmid was confirmed by DNA sequencing.
To Figure 1 . Schematic representation of generating pTac-elk. PCR product 1 was generated using pGEX-2T as a template and primers up-tac and minus-elk. PCR product 2 was generated using the trpelk plasmid (Stratagene) and primers plus-tac and down-elk. The resulting products were purified, mixed, and reamplified with primers up-tac and down-elk. This product was digested with NcoI and ApaLI and used to replace the NcoI-ApaLI fragment of the trp-elk plasmid (containing the trp promoter).
tured in 2 mL LB media. The next day, this culture was used to inoculate larger cultures at 1:50 dilution in Terrific Broth (6) . After 3 h of incubation, 1 mM IPTG was added to the culture medium. After an additional 2 h of incubation, the cells were harvested. Cell pellets were resuspended and boiled in 1× SDS loading buffer, and cell equivalents were electrophoresed on SDSacrylamide gels. The separated proteins were then analyzed by immunoblotting with phospho-Y-705 Stat3 antibody (Cell Signaling, Beverly, MA, USA). As seen in Figure 2 , IPTG-inducible phosphorylation of the GST-Stat3 fusion protein was observed. Since the antibody employed specifically recognizes phospho-Y-705, this indicated that the fusion protein was specifically phosphorylated on tyrosine-705. Furthermore, comparison of the signal before and after IPTG induction strongly indicates that the expression level of the elk kinase was controlled by the tac promoter (the faint band in the uninduced lane indicates that the lacI q control of the lac and tac promoters is slightly leaky). We have found that cells grown from different colonies from the same plate result in different magnitudes of induction. Therefore, we suggest growing several independent clones from each transformation to find those with maximal induction of protein phosphorylation.
The primary advantage of this method over the existing system is the improved convenience of producing the target phosphoprotein. If the target protein is under control of the lac or tac promoter, then the expression of the target protein and kinase can be induced simultaneously. This is advantageous if the target protein is toxic to the host E. coli strain. Furthermore, there is no need to change the cells to minimal medium and induce with indole acrylic acid that also facilitates the production of phosphoprotein. We have successfully used these cells to purify several tyrosine phosphoproteins, including fulllength Stat3α and portions of the cytoplasmic domain of the receptor tyrosine kinase erbB2. We have detected inducible tyrosine phosphorylation with all proteins we have tested to date. Since pTac-elk plasmid does not contain lacI q , tight control of the expression of the elk kinase requires the use of an E. coli strain that expresses lac repressor. Although the GST-Stat protein we presented here to demonstrate the usefulness of the system was rather small (only approximately 200 amino acids of the Stat3 protein), we have detected tyrosine phosphorylation of full length Stat3α, which is approximately 92 kDa, indicating that larger proteins are also efficient substrates of the kinase. This system is designed to use the expression of a promiscuous tyrosine kinase to phosphorylate proteins expressed in bacteria. How specific is the kinase activity? We have shown using a specific antibody that the only known tyrosine that is phosphorylated in mammalian cells is properly phosphorylated using these Elk-expressing cells. Another group, using the BL21(DE3)TBK1 cells (Stratagene) to phosphorylate Stat3β, found that tyrosine-705 was the major phosphorylated residue following purification and liquid chromatographymass spectrometic analysis LC-MS (1). We suspect that tyrosine residues on proteins other than those that are "natural" substrates of tyrosine kinases are also phosphorylated by expression of Elk. This is based on the fact that numerous bands are detected in extracts from IPTG-induced cells using the panphosphotyrosine specific antibody 4G10 (Upstate Biotechnology, Lake Placid, NY, USA). This indicates that many endogenous E. coli proteins that normally do not undergo tyrosine phosphorylation are substrates for the Elk kinase. Based on this observation, the efficiency and specificity of the tyrosine phosphorylation of any target protein will have to be determined empirically.
In summary, the pTac-elk plasmid offers a more convenient means to generate mammalian tyrosine phosphoproteins in bacteria than is currently available. Since this post-translational modification is essential for the function of proteins in numerous signal transduction pathways, the use of this system will allow for the generation of phosphoproteins for in vitro studies such as protein-protein interactions or X-ray crystallography, in which posttranslational modification by tyrosine phosphorylation is required. 
